RetractedArticleTechnology in cancer research & treatment

Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma.

Ling Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.